Healthcare Triangle, Inc. — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024; comparative period is Q1 2023. The unaudited consolidated statements are in thousands of dollars, except per-share data. Healthcare Triangle provides cloud, software, data and managed IT services to healthcare and life sciences organizations. At quarter-end, it reported 23 full-time employees and 125 subcontractors.
Financial performance and position
| Metric | Q1 2024 | Q1 2023 / comparison |
|---|---|---|
| Revenue | $4.109 million | $9.838 million; down 58% |
| Gross profit and margin | $1.014 million; 24.7% | $1.593 million; 16.2% |
| Operating loss | $1.708 million | $3.209 million |
| Net loss / diluted loss per share | $1.862 million / $0.42 | $3.278 million / $0.79 |
| Operating cash flow | $(50,000) | $(1.603) million |
| Cash at quarter-end | $301,000 | $267,000 at March 31, 2023 |
| Current assets / current liabilities | $3.169 million / $5.995 million | Current ratio 0.5, versus 0.7 at December 31, 2023 |
| Stockholders’ equity (deficit) | $(511,000) | $538,000 at December 31, 2023 |
Q1 financing cash outflow was $883,000, and investing cash flow was zero; cash declined by $933,000 from year-end. The MD&A cash-flow summary instead reports financing outflow of $833,000, an apparent inconsistency in the filing. Current liabilities include $1.795 million of short-term borrowings; long-term convertible notes were $888,000. The notes separately report $1.25 million outstanding on the convertible financing, split between short-term borrowings and long-term notes. The Seacoast receivables-backed facility was $1.295 million. Warrant liability was $1.144 million.
Changes versus the prior comparable period
- Revenue fell $5.729 million. Managed services and support declined 69% to $1.996 million; software services declined 33% to $2.025 million; platform services declined 74% to $88,000.
- Management attributes approximately $4.1 million of lost revenue to termination of Customer 1’s Supplier Master Services Agreement, effective February 4, 2024. Customer 1 revenue fell 84% year over year.
- Cost of revenue declined 62%, less than the revenue decline, while gross margin improved to 24.7% from 16.2%. Operating expenses declined overall; interest expense rose to $149,000 from $62,000, which management attributes to convertible notes.
- Top five customers represented 70% of revenue, versus 80% in Q1 2023. The filing identifies Customer 1 as 20% of Q1 2024 revenue, compared with 50% a year earlier.
Liquidity, outlook and risks
- Going concern: The company states that operating losses raise substantial doubt about its ability to continue as a going concern. It also says it believes existing cash and expected operating cash flows will meet working-capital needs for the next 12 months; that assessment depends on uncertain future cash generation and financing access.
- Funding plans and dilution: The filing says the company had sold $956,000 through its at-the-market (ATM) program as of the plan date, with $1.444 million of capacity remaining and a possible further capacity increase of approximately $500,000. SecureKloud Technologies, the parent, was willing to invest an additional $5 million during FY2024. These are plans or stated willingness, not assurances of funding.
- The company reported a December 2023 agreement for up to $5.2 million in principal of senior secured notes with a 15% original issue discount. It said it anticipated repaying the first tranche by December 31, 2024, and expected further share issuances and a positive effect on equity by Q4 2024. In Q1, it issued 417,395 shares to repay $787,000 of note obligations. Subsequent to quarter-end, it reported additional ATM share sales and note conversions.
- Management’s strategy emphasizes growing recurring managed, platform and subscription services. It said SaaS offerings remain at an early marketing stage and customer acceptance and revenue impact are uncertain. The filing provides no quantified revenue or earnings guidance.
- Risks include weak liquidity, continuing losses, customer concentration, reliance on financing, debt repayment, long customer procurement cycles, competition, and technology, security, privacy and regulatory challenges. Management said there was no major Q1 2024 impact from COVID-19. It reported no material outside-ordinary-course litigation and no material changes to the risk factors in its March 18, 2024 Form 10-K.
- Management reported disclosure controls and procedures effective as of March 31, 2024, and no material changes to internal control over financial reporting during the quarter.
Important facts for investors to verify
- Reconcile the MD&A’s $833,000 financing outflow with the cash-flow statement’s $883,000 figure and the reported $933,000 net cash decline.
- Confirm actual availability, timing and terms of ATM proceeds, the proposed parent investment, and any additional note tranches; assess the impact of share issuances and conversions on dilution.
- Review the going-concern disclosure against cash of $301,000, a current ratio of 0.5 and the company’s stated 12-month liquidity expectation.
- Assess the revenue and renewal outlook following the termination of Customer 1’s agreement and the continuing reliance on a concentrated customer base.
- Clarify the company’s total debt and repayment schedule across the convertible notes, receivables-backed facility and other short-term borrowings.